22nd Century Group Company Profile (NYSE:XXII)

About 22nd Century Group (NYSE:XXII)

22nd Century Group logo22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NYSE:XXII
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $126.34 million
  • Outstanding Shares: 90,895,000
Average Prices:
  • 50 Day Moving Avg: $1.35
  • 200 Day Moving Avg: $1.10
  • 52 Week Range: $0.77 - $1.71
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.90
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $11.49 million
  • Price / Sales: 11.00
  • Book Value: $0.24 per share
  • Price / Book: 5.79
Profitability:
  • EBIDTA: ($10,260,000.00)
Misc:
  • Average Volume: 941,830 shs.
  • Short Ratio: 4.35
 

Frequently Asked Questions for 22nd Century Group (NYSE:XXII)

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "XXII."

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSE:XXII) posted its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The business earned $3.02 million during the quarter. View 22nd Century Group's Earnings History.

Where is 22nd Century Group's stock going? Where will 22nd Century Group's stock price be in 2017?

1 brokers have issued 1-year price objectives for 22nd Century Group's stock. Their predictions range from $3.50 to $3.50. On average, they anticipate 22nd Century Group's share price to reach $3.50 in the next twelve months. View Analyst Ratings for 22nd Century Group.

What are analysts saying about 22nd Century Group stock?

Here are some recent quotes from research analysts about 22nd Century Group stock:

  • 1. According to Zacks Investment Research, "22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. " (5/17/2017)
  • 2. Chardan Capital analysts commented, "We expect 22nd Century to report Q4 results this week. Our revenue estimate for the quarter is $3.1 million, equivalent to Q3 results. For the full year this results in revenue of $12 million. We expect the company on its earnings call to focus on recent communications with the FDA regarding its PMTA (Premarket Tobacco Product Applications), the MRTP (Modified Risk Tobacco Product) applications and a path forward for X-22. Earlier this month the FDA granted a guidance meeting to discuss X-22 and the ways 22nd Century could attempt to win approval for X-22 as a prescription-based aid for smoking cessation. The company has also received written feedback on the MRTP application for Brand A, the company's very low nicotine (VLN) cigarette. As we progress through the year we expect additional milestones to be reached on 22nd Century's attempt to use its proprietary technology to create VLN products for the smoking cessation market." (3/7/2017)

Are investors shorting 22nd Century Group?

22nd Century Group saw a drop in short interest in April. As of April 28th, there was short interest totalling 4,414,704 shares, a drop of 7.3% from the April 13th total of 4,763,832 shares. Based on an average daily volume of 1,048,744 shares, the days-to-cover ratio is presently 4.2 days. Approximately 6.0% of the shares of the company are sold short.

Who are some of 22nd Century Group's key competitors?

Who owns 22nd Century Group stock?

22nd Century Group's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.71%), Geode Capital Management LLC (0.49%) and National Asset Management Inc. (0.19%). Company insiders that own 22nd Century Group stock include John T Brodfuehrer, Joseph Pandolfino and Michael Robert Moynihan. View Institutional Ownership Trends for 22nd Century Group.

Who bought 22nd Century Group stock? Who is buying 22nd Century Group stock?

22nd Century Group's stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc. and National Asset Management Inc.. View Insider Buying and Selling for 22nd Century Group.

How do I buy 22nd Century Group stock?

Shares of 22nd Century Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of 22nd Century Group stock cost?

One share of 22nd Century Group stock can currently be purchased for approximately $1.39.

Analyst Ratings

Consensus Ratings for 22nd Century Group (NYSE:XXII) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.50 (151.80% upside)

Analysts' Ratings History for 22nd Century Group (NYSE:XXII)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/7/2017Chardan CapitalReiterated RatingBuy$3.50N/AView Rating Details
(Data available from 5/22/2015 forward)

Earnings

Earnings History for 22nd Century Group (NYSE:XXII)
Earnings by Quarter for 22nd Century Group (NYSE:XXII)
Earnings History by Quarter for 22nd Century Group (NYSE:XXII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2016Q1($0.03)($0.04)$3.02 millionViewN/AView Earnings Details
11/9/2015Q3($0.03)($0.04)$2.67 millionViewN/AView Earnings Details
8/4/2015Q215($0.02)($0.02)$1.30 million$2.31 millionViewN/AView Earnings Details
2/6/2015($0.03)($0.09)ViewN/AView Earnings Details
11/14/2014Q314($0.03)($0.05)$0.06 millionViewN/AView Earnings Details
8/14/2014($0.03)($0.03)$0.02 millionViewN/AView Earnings Details
5/2/2014($0.03)($0.09)$0.45 millionViewN/AView Earnings Details
1/30/2014Q4($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for 22nd Century Group (NYSE:XXII)
Current Year EPS Consensus Estimate: $-0.10 EPS
Next Year EPS Consensus Estimate: $-0.10 EPS

Dividends

Dividend History for 22nd Century Group (NYSE:XXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for 22nd Century Group (NYSE:XXII)
Insider Trades by Quarter for 22nd Century Group (NYSE:XXII)
Institutional Ownership by Quarter for 22nd Century Group (NYSE:XXII)
Insider Trades by Quarter for 22nd Century Group (NYSE:XXII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/31/2016Michael Robert MoynihanVPSell100,000$1.28$128,000.00View SEC Filing  
3/29/2016John T BrodfuehrerCFOBuy12,500$0.77$9,625.00View SEC Filing  
11/3/2015Michael Robert MoynihanVPSell50,000$1.40$70,000.00View SEC Filing  
6/30/2015Joseph PandolfinoDirectorSell91,178$0.95$86,619.10View SEC Filing  
12/31/2014Joseph PandolfinoDirectorSell105,124$1.65$173,454.60View SEC Filing  
12/26/2014Joseph PandolfinoDirectorSell41,722$1.54$64,251.88View SEC Filing  
12/22/2014Joseph PandolfinoDirectorSell52,683$1.60$84,292.80View SEC Filing  
12/17/2014Joseph PandolfinoDirectorSell75,768$1.62$122,744.16View SEC Filing  
12/11/2014Joseph PandolfinoDirectorSell67,836$1.65$111,929.40View SEC Filing  
5/9/2014Richard M SandersDirectorBuy20,000$2.23$44,600.00View SEC Filing  
4/23/2014Michael Robert MoynihanVPSell100,000$2.44$244,000.00View SEC Filing  
3/12/2014Joseph PandolfinoCEOSell95,000$5.73$544,350.00View SEC Filing  
12/10/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.55$15,500.00View SEC Filing  
12/3/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.35$13,500.00View SEC Filing  
11/19/2013Clearwater Partners, LlcMajor ShareholderSell30,074$1.09$32,780.66View SEC Filing  
11/13/2013Clearwater Partners, LlcMajor ShareholderSell11,826$0.98$11,589.48View SEC Filing  
11/11/2013Clearwater Partners, LlcMajor ShareholderSell7,100$1.03$7,313.00View SEC Filing  
11/7/2013Clearwater Partners, LlcMajor ShareholderSell9,000$1.15$10,350.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for 22nd Century Group (NYSE:XXII)
Latest Headlines for 22nd Century Group (NYSE:XXII)
Source:
DateHeadline
americanbankingnews.com logo22nd Century Group Inc (XXII) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 17 at 11:00 AM
businesswire.com logo22nd Century Raises 2017 Revenue Projection to $16Million – Another Record Year - Business Wire (press release)
www.businesswire.com - May 11 at 3:22 PM
americanbankingnews.com logoShort Interest in 22nd Century Group Inc (XXII) Drops By 7.3%
www.americanbankingnews.com - May 10 at 7:02 AM
finance.yahoo.com logo22nd Century Raises 2017 Revenue Projection to $16Million – Another Record Year
finance.yahoo.com - May 9 at 8:39 AM
finance.yahoo.com logo22nd Century Group Files 2017 First Quarter Report and Announces Conference Call to Provide Business Update
finance.yahoo.com - May 8 at 8:58 PM
americanbankingnews.com logo22nd Century Group Inc (XXII) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - May 5 at 8:08 PM
americanbankingnews.com logo 22nd Century Group Inc (XXII) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - May 4 at 9:16 AM
americanbankingnews.com logoVery Favorable News Coverage Very Likely to Affect 22nd Century Group (XXII) Share Price
www.americanbankingnews.com - May 2 at 10:40 AM
streetinsider.com logoPre-Open Movers 05/01: (OCN) (XXII) (TWTR) Higher; (FNBC) (AEZS) (ITCI) Lower (more...)
www.streetinsider.com - May 1 at 7:50 PM
streetinsider.com logo22nd Century Group (XXII) Receives FDA Clearance for Trial of BRAND B Low Tar-to-Nicotine Ratio Cigarettes - StreetInsider.com
www.streetinsider.com - May 1 at 9:31 AM
finance.yahoo.com logoFDA Authorizes Clinical Trial for 22nd Century’s BRAND B Low Tar-to-Nicotine Ratio Cigarettes
finance.yahoo.com - May 1 at 9:31 AM
americanbankingnews.com logoFavorable Media Coverage Very Likely to Affect 22nd Century Group (XXII) Stock Price
www.americanbankingnews.com - April 29 at 9:20 AM
americanbankingnews.com logoPositive Media Coverage Unlikely to Affect 22nd Century Group (XXII) Stock Price
www.americanbankingnews.com - April 26 at 8:12 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) Short Interest Update
www.americanbankingnews.com - April 25 at 8:48 PM
finance.yahoo.com logo22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China
finance.yahoo.com - April 25 at 7:41 PM
americanbankingnews.com logo22nd Century Group (XXII) Receives Coverage Optimism Score of 0.40
www.americanbankingnews.com - April 22 at 8:53 AM
finance.yahoo.com logo22nd Century Will Play Leading Role in Industrial Hemp Industry
finance.yahoo.com - April 21 at 1:26 AM
americanbankingnews.com logo22nd Century Group (XXII) Earning Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 19 at 9:09 AM
americanbankingnews.com logoZacks: 22nd Century Group Inc (XXII) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - April 18 at 10:32 AM
americanbankingnews.com logoSomewhat Positive News Coverage Likely to Impact 22nd Century Group (XXII) Share Price
www.americanbankingnews.com - April 16 at 8:50 AM
americanbankingnews.com logoFavorable Press Coverage Very Likely to Impact 22nd Century Group (XXII) Stock Price
www.americanbankingnews.com - April 13 at 9:25 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) Short Interest Down 2.9% in March
www.americanbankingnews.com - April 12 at 7:05 AM
finance.yahoo.com logoNew Zealand Study Recommends 22nd Century’s VLN Cigarettes as an Effective Tobacco Control Strategy
finance.yahoo.com - April 7 at 1:39 PM
finance.yahoo.com logoCan The Uptrend Continue for 22nd Century Group (XXII)?
finance.yahoo.com - April 7 at 1:39 PM
americanbankingnews.com logo 22nd Century Group Inc (XXII) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 6 at 9:52 AM
thestreet.com logoCollect Smokin' Hot Profits From This Marijuana Biotech
www.thestreet.com - March 30 at 8:37 PM
businesswire.com logo22nd Century's “Non- or Minimally-Addictive” Cigarettes Gaining Support of Leading Tobacco Scientists around the World - Business Wire (press release)
www.businesswire.com - March 30 at 3:37 PM
finance.yahoo.com logo22nd Century’s “Non- or Minimally-Addictive” Cigarettes Gaining Support of Leading Tobacco Scientists around the World
finance.yahoo.com - March 30 at 3:37 PM
bizjournals.com logo22nd Century reports 'major breakthrough' in marijuana research
www.bizjournals.com - March 29 at 8:23 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - March 25 at 7:38 AM
cnbc.com logo22nd Century reports 3Q loss
www.cnbc.com - November 8 at 8:32 PM
businesswire.com logoFormer Santa Fe Natural Tobacco Company Executive Joins 22nd Century - Business Wire (press release)
www.businesswire.com - October 26 at 12:03 PM
biz.yahoo.com logo22ND CENTURY GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi
biz.yahoo.com - October 17 at 8:03 PM
businesswire.com logo22nd Century Group Announces Above-Market Offering for $11.4 Million - Business Wire (press release)
www.businesswire.com - October 15 at 7:54 PM

Social

22nd Century Group (XXII) Chart for Monday, May, 22, 2017

This page was last updated on 5/22/2017 by MarketBeat.com Staff